Back
Corporate News
Krebs Biochemicals submits regulatory certificates to BSE and NSE for Q3 2026
05-Oct-2026, 12:14
Krebs Biochemicals & Industries Limited submitted certificates to the BSE Limited and National Stock Exchange of India Ltd on October 5, 2026, in compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026, with KFIN Technologies Limited acting as the Registrar and Share Transfer Agent.